Skip to content
value.today

Terns Pharmaceuticals, Inc.

TERNUnlisted company
$4.4 Blast known market cap, Mar 2026 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Terns Pharmaceuticals, Inc. timeline

1 events, 2021
  1. 2021
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Terns Pharmaceuticals, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Terns Pharmaceuticals, Inc.

Acquisitions and changes
No longer listed: ticker TERN is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$1.2 B$2.4 B$3.6 B$4.8 B2023202420252026

World rank over time

▲ up 19,202 places since 2022
2022-01-07: #20457#20,45720222022-12-25: #15499#15,49920222023-07-30: #14224#14,22420232024-01-05: #13758#13,75820242026-03-08: #1255#1,2552026

Rank in USA: #4,070 (Jan 2022) · #3,176 (Dec 2022) · #2,905 (Jul 2023) · #2,685 (Jan 2024) · #106 (Mar 2026)

Mutual funds holding Terns Pharmaceuticals, Inc.#

1 funds hold shares worth $1 M. Since their previous reports 0 added shares and 181 sold, selling $1.2 B net.
Mutual funds holding Terns Pharmaceuticals, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC11,905$1 M—0.38%—Mar 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 1 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Markets and events: Terns Pharmaceuticals, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-04-30
5.5 M
1.46 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-05-04 23:50 UTC, code D, resumed 04:00 UTC
  • 2025-12-08 19:40 UTC, code T3, resumed 20:05 UTC

Fails to deliver

  • : 1,007 shares at $52.95
  • : 5,224 shares at $52.93
  • : 22,564 shares at $52.94
  • : 37 shares at $52.83
  • : 537 shares at $52.84

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Where Terns Pharmaceuticals, Inc. operates: 1 country#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.

Present: offices, subsidiaries, branches or revenue (1 country)Nothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.

Only the headquarters country is on file for Terns Pharmaceuticals, Inc.: no subsidiaries, branches, offices or country revenue elsewhere in the GLEIF register, its SEC filings or Wikidata.

Terns Pharmaceuticals, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Terns Pharmaceuticals, Inc.🇺🇸$4.4 B———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Mar 8, 2026 (last known)
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Terns Pharmaceuticals, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Terns Pharmaceuticals, Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Terns Pharmaceuticals, Inc.? Suggest a correction